Cite

HARVARD Citation

    Pengo, V. et al. (2021). Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure. Journal of thrombosis and haemostasis. pp. 531-535. [Online]. 
  
Back to record